Literature DB >> 16456542

PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling.

Yoko Takahashi1, Fabiana C Morales, Erica L Kreimann, Maria-Magdalena Georgescu.   

Abstract

PTEN, a tumor suppressor frequently inactivated in many human cancers, directly antagonizes the activity of phosphatidylinositol-3-OH kinase (PI3K) by dephosphorylating phosphoinositides. We show here that PTEN interacts directly with the NHERF1 and NHERF2 (Na+/H+ exchanger regulatory factor) homologous adaptor proteins through the PDZ motif of PTEN and the PDZ1 domain of NHERF1 or both PDZ domains of NHERF2. NHERFs were shown to interact directly with platelet-derived growth factor receptor (PDGFR), and we demonstrate the assembly of a ternary complex between PTEN, NHERFs and PDGFR. The activation of the PI3K pathway after PDGFR stimulation was prolonged in NHERF1(-/-) mouse embryonic fibroblasts as compared to wild-type cells, consistent with defective PTEN recruitment to PDGFR in the absence of NHERF1. Depletion of NHERF2 by small interfering RNA similarly increased PI3K signaling. Phenotypically, the loss of NHERF1 enhanced the PDGF-induced cytoskeletal rearrangements and chemotactic migration of the cells. These data indicate that, in normal cells, NHERF proteins recruit PTEN to PDGFR to restrict the activation of the PI3K.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16456542      PMCID: PMC1383560          DOI: 10.1038/sj.emboj.7600979

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  39 in total

1.  Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex.

Authors:  F Vazquez; S R Grossman; Y Takahashi; M V Rokas; N Nakamura; W R Sellers
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

2.  Oligomerization of NHERF-1 and NHERF-2 PDZ domains: differential regulation by association with receptor carboxyl-termini and by phosphorylation.

Authors:  A G Lau; R A Hall
Journal:  Biochemistry       Date:  2001-07-24       Impact factor: 3.162

3.  Distinct cell type-specific expression of scaffolding proteins EBP50 and E3KARP: EBP50 is generally expressed with ezrin in specific epithelia, whereas E3KARP is not.

Authors:  Janet Ingraffea; David Reczek; Anthony Bretscher
Journal:  Eur J Cell Biol       Date:  2002-02       Impact factor: 4.492

4.  Membrane-binding and activation mechanism of PTEN.

Authors:  Sudipto Das; Jack E Dixon; Wonhwa Cho
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

5.  N-terminal PDZ domain is required for NHERF dimerization.

Authors:  S Shenolikar; C M Minkoff; D A Steplock; C Evangelista; M Liu; E J Weinman
Journal:  FEBS Lett       Date:  2001-02-02       Impact factor: 4.124

6.  Functional definition of relevant epitopes on the tumor suppressor PTEN protein.

Authors:  Amparo Andrés-Pons; Miguel Valiente; Josema Torres; Anabel Gil; Isabel Roglá; Francisca Ripoll; Javier Cervera; Rafael Pulido
Journal:  Cancer Lett       Date:  2004-11-10       Impact factor: 8.679

Review 7.  Protean PTEN: form and function.

Authors:  Kristin A Waite; Charis Eng
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

8.  Ligand-induced recruitment of Na+/H+-exchanger regulatory factor to the PDGF (platelet-derived growth factor) receptor regulates actin cytoskeleton reorganization by PDGF.

Authors:  Jean-Baptiste Demoulin; Jeong Kon Seo; Simon Ekman; Eva Grapengiesser; Ulf Hellman; Lars Rönnstrand; Carl-Henrik Heldin
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

9.  Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase.

Authors:  Lenin Mahimainathan; Goutam Ghosh Choudhury
Journal:  J Biol Chem       Date:  2004-01-12       Impact factor: 5.157

10.  Synergy in tumor suppression by direct interaction of neutral endopeptidase with PTEN.

Authors:  Makoto Sumitomo; Akira Iwase; Rong Zheng; Daniel Navarro; David Kaminetzky; Ruoqian Shen; Maria-Magdalena Georgescu; David M Nanus
Journal:  Cancer Cell       Date:  2004-01       Impact factor: 31.743

View more
  100 in total

1.  Phosphorylation of EBP50 negatively regulates β-PIX-dependent Rac1 activity in anoikis.

Authors:  J-Y Chen; Y-Y Lin; T-S Jou
Journal:  Cell Death Differ       Date:  2012-02-03       Impact factor: 15.828

2.  Novel bioactivity of NHERF1 in corneal neovascularization.

Authors:  Peng Chen; Ye Wang; Lingling Yang; Changyou Li; Yao Wang; Lixin Xie; Yiqiang Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-07-10       Impact factor: 3.117

3.  Alterations in the proteome of the NHERF2 knockout mouse jejunal brush border membrane vesicles.

Authors:  M Donowitz; S Singh; P Singh; M Chakraborty; Y Chen; R Murtazina; M Gucek; R N Cole; N C Zachos; F F Salahuddin; O Kovbasnjuk; N Broere; W G Smalley-Freed; A B Reynolds; A L Hubbard; U Seidler; E Weinman; H R de Jonge; B M Hogema; X Li
Journal:  Physiol Genomics       Date:  2011-03-22       Impact factor: 3.107

4.  PTEN in liver diseases and cancer.

Authors:  Marion Peyrou; Lucie Bourgoin; Michelangelo Foti
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

Review 5.  Turning off AKT: PHLPP as a drug target.

Authors:  Alexandra C Newton; Lloyd C Trotman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

Review 6.  PTEN function: the long and the short of it.

Authors:  Benjamin D Hopkins; Cindy Hodakoski; Douglas Barrows; Sarah M Mense; Ramon E Parsons
Journal:  Trends Biochem Sci       Date:  2014-03-18       Impact factor: 13.807

7.  p85 Associates with unphosphorylated PTEN and the PTEN-associated complex.

Authors:  Rosalia Rabinovsky; Panisa Pochanard; Chontelle McNear; Saskia M Brachmann; Jonathan S Duke-Cohan; Levi A Garraway; William R Sellers
Journal:  Mol Cell Biol       Date:  2009-07-27       Impact factor: 4.272

8.  Ezrin-radixin-moesin-binding phosphoprotein (EBP50), an estrogen-inducible scaffold protein, contributes to biliary epithelial cell proliferation.

Authors:  Laura Fouassier; Peter Rosenberg; Martine Mergey; Bruno Saubaméa; Audrey Clapéron; Nils Kinnman; Nicolas Chignard; Gunilla Jacobsson-Ekman; Birgitta Strandvik; Colette Rey; Véronique Barbu; Rolf Hultcrantz; Chantal Housset
Journal:  Am J Pathol       Date:  2009-03       Impact factor: 4.307

9.  Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect.

Authors:  Shuyu E; Yun-Ju Lai; Ryoko Tsukahara; Chen-Shan Chen; Yuko Fujiwara; Junming Yue; Jei-Hwa Yu; Huazhang Guo; Akio Kihara; Gábor Tigyi; Fang-Tsyr Lin
Journal:  J Biol Chem       Date:  2009-03-17       Impact factor: 5.157

Review 10.  Regulation and modulation of PTEN activity.

Authors:  Elahe Naderali; Amir Afshin Khaki; Jafar Soleymani Rad; Alireza Ali-Hemmati; Mohammad Rahmati; Hojjatollah Nozad Charoudeh
Journal:  Mol Biol Rep       Date:  2018-08-25       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.